Targeting neuroinflammation for therapeutic intervention in neurodegenerative pathologies: A role for the peptide analogue of thymulin (PAT)

Abstract

Introduction: Inflammation has a vital task in protecting the organism, but when deregulated, it can have serious pathological consequences. The central nervous system (CNS) is capable of mounting immune and inflammatory responses, albeit different from that observed in the periphery. Neuroinflammation, however, can be a major contributor to neurodegenerative diseases and constitute a major challenge for medicine and basic research. Areas covered: Both innate and adaptive immune responses normally play an important role in homeostasis within the CNS. Microglia, astrocytes and neuronal cells express a wide array of toll-like receptors (TLR) that can be upregulated by infection, trauma, injuries and various exogenic or endogenic factors. Chronic hyper activation of brain immune cells can result in neurotoxic actions due to excessive production of several pro-inflammatory mediators. Several studies have recently described an important role for targeting receptors such as nicotinic receptors located on cells in the CNS or in other tissues for the control of inflammation. Expert opinion: Thymulin and its synthetic peptide analogue (PAT) appear to exert potent anti-inflammatory effects at the level of peripheral tissues as well as at the level of the brain. This effect involves, at least partially, the activation of cholinergic mechanisms. © 2012 Informa UK, Ltd.Al-Amin H, 2011, EXP NEUROL, V228, P30, DOI 10.1016-j.expneurol.2010.11.005; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038-nri1664; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111-j.1365-2567.2009.03225.x; Arroyo DS, 2011, INT IMMUNOPHARMACOL, V11, P1415, DOI 10.1016-j.intimp.2011.05.006; BACH JF, 1983, CLIN IMMUNOL ALLERGY, V3, P133; BACH JF, 1977, NATURE, V266, P55, DOI 10.1038-266055a0; BANKS WA, 1991, J PHARMACOL EXP THER, V259, P988; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073-pnas.0807419105; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046-j.1460-9568.2000.00110.x; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084-jem.20011714; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016-j.bcp.2007.07.011; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210-er.17.1.64; Bjorkqvist M, 2009, NEURON, V64, P21, DOI 10.1016-j.neuron.2009.09.034; Blalock JE, 2002, J EXP MED, V195, pF25, DOI 10.1084-jem.20020602; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016-j.pneurobio.2005.06.004; Boche D, 2006, NEUROBIOL DIS, V22, P638, DOI 10.1016-j.nbd.2006.01.004; Borovikova LV, 2000, NATURE, V405, P458; Brenneman DE, 1996, J CLIN INVEST, V97, P2299, DOI 10.1172-JCI118672; Butchi NB, 2011, AM J PATHOL, V179, P783, DOI 10.1016-j.ajpath.2011.04.011; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038-nn1715; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111-j.1600-065X.2006.00441.x; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016-0014-5793(87)80305-8; Conejero-Goldberg C, 2008, NEUROSCI BIOBEHAV R, V32, P693, DOI 10.1016-j.neubiorev.2007.10.007; Correa F, 2010, GLIA, V58, P135, DOI 10.1002-glia.20907; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046-j.1365-2559.2001.01082.x; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038-sj.bjp.0707264; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016-j.jneuroim.2004.11.010; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002-glia.440070113; Elkabes S, 1996, J NEUROSCI, V16, P2508; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016-S0002-9440(10)63438-4; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186-1750-1326-4-47; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016-j.it.2006.11.004; Gao BX, 2010, PAIN, V149, P33, DOI 10.1016-j.pain.2010.01.007; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016-j.it.2008.05.002; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073-pnas.1017975108; Giuliani F, 2003, J IMMUNOL, V171, P368; Glass CK, 2010, CELL, V140, P918, DOI 10.1016-j.cell.2010.02.016; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046-j.1440-1681.2000.03200.x; Hansen MK, 1998, J NEUROSCI, V18, P2247; Henriques-Coelho T, 2008, ENDOCRINOLOGY, V149, P4367, DOI 10.1210-en.2008-0018; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038-nm1269; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038-ni.1863; Kim YS, 2006, EXP MOL MED, V38, P333; Konat GW, 2006, J NEUROCHEM, V99, P1, DOI 10.1111-j.1471-4159.2006.04076.x; Konsman JP, 2008, EUR J NEUROSCI, V28, P2499, DOI 10.1111-j.1460-9568.2008.06549.x; LEE SC, 1993, J IMMUNOL, V150, P2659; Loram LC, 2010, BRAIN BEHAV IMMUN, V24, P959, DOI 10.1016-j.bbi.2010.03.008; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111-j.1476-5381.2009.00331.x; Menghetti L, 2005, BRAIN RES BRAIN RES, V48, P251; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046-j.1460-9568.2001.01418.x; Nathan C, 2010, CELL, V140, P871, DOI 10.1016-j.cell.2010.02.029; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093-brain-124.11.2203; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523-JNEUROSCI.4786-03.2004; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038-nrn752; Niehaus I., 2003, AD PD 6 INT C, P1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126-science.1110647; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016-S0006-3223(00)01125-2; Olson JK, 2004, J IMMUNOL, V173, P3916; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016-j.coi.2005.11.012; Peng H, 2010, J NEUROSCI RES, V88, P1041, DOI 10.1002-jnr.22269; PLEAU JM, 1979, IMMUNOL LETT, V1, P179, DOI 10.1016-0165-2478(79)90025-7; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038-nrn2398; Pul R, 2011, EXPERT OPIN BIOL TH, V11, P343, DOI 10.1517-14712598.2011.552884; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002-glia.20467; Ramirez BG, 2005, J NEUROSCI, V25, P190; Reggiani PC, 2009, ANN NY ACAD SCI, V1153, P98, DOI 10.1111-j.1749-6632.2008.03964.x; Reyes TM, 1998, AM J PHYSIOL-REG I, V274, pR139; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038-nri2565; Ron-Harel N, 2010, BRAIN BEHAV IMMUN, V25, P1036; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111-j.1365-2796.2009.02098.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126-science.1209985; Rowbotham MC, 2009, PAIN, V146, P245, DOI 10.1016-j.pain.2009.06.013; Saade NE, 2003, NEUROSCIENCE, V119, P155, DOI 10.1016-S0306-4522(03)00072-1; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016-j.cytogfr.2010.09.002; Safieh-Garabedian B, 2002, BRIT J PHARMACOL, V136, P947, DOI 10.1038-sj.bjp.0704793; Safieh-Garabedian B, 2004, CURR DRUG TARGETS CN, V3, P61; Safieh-Garabedian B, 2011, NEUROPHARMACOLOGY, V60, P496, DOI 10.1016-j.neuropharm.2010.11.004; SafiehGarabedian B, 1996, BRAIN RES, V717, P179, DOI 10.1016-0006-8993(95)01532-9; Safieh-Garabedian B, 2010, SOC NEUROSCI; Safieh-Garabedian B, 2000, NEUROPHARMACOLOGY, V39, P1653, DOI 10.1016-S0028-3908(99)00247-6; Safieh-Garabedian B, 2003, NEUROSCIENCE, V121, P865, DOI 10.1016-S0306-4522(03)00500-1; Safieh-Garabedian B, 2012, IASP M MIL; Saunders NR, 2008, TRENDS NEUROSCI, V31, P279, DOI 10.1016-j.tins.2008.03.003; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016-j.neuron.2006.01.022; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016-S0301-0082(98)00069-0; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002-glia.10154; Streit Wolfgang J., 2005, Current Alzheimer Research, V2, P187, DOI 10.2174-1567205053585765; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002-jnr.20850; Szelenyi J, 2001, BRAIN RES BULL, V54, P329, DOI 10.1016-S0361-9230(01)00428-2; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016-j.jmb.2004.12.031; Vaz AR, 2011, EXP NEUROL, V229, P381, DOI 10.1016-j.expneurol.2011.03.004; Waldburger JM, 2008, ARTHRITIS RHEUM, V58, P3439, DOI 10.1002-art.23987; Wang H, 2003, NATURE, V421, P384, DOI 10.1038-nature01339; Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049-jimmunol.0801218; Xin JP, 2011, BRAIN BEHAV IMMUN, V25, P820, DOI 10.1016-j.bbi.2010.08.004; Zhang R, 2008, BIOCHEM BIOPH RES CO, V372, P816, DOI 10.1016-j.bbrc.2008.05.128; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111-j.1471-4159.2009.06263.x; Ziemssen T, 2002, BRAIN, V125, P2381, DOI 10.1093-brain-awf252; Zipp F, 2006, TRENDS NEUROSCI, V29, P518, DOI 10.1016-j.tins.2006.07.00623